Inflammatory state in patients with atrial fibrillation before and after electrical cardioversion;Estado inflamatorio de los pacientes con fibrilación auricular antes y después de la cardioversión eléctrica

Medicina Intensiva

Volumn 31, Issue 3, 2007, Pages 126-132

  Gomez Martinez E ^a   Borras Palle S ^a   Valls Grima, F ^a   Miralles Serrano, Ll ^a   Molto Guillamont L ^a   Jarabo Bueno, M M ^a   Gomez Casals V ^a   Valentin Segura V ^a  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

Atrial fibrillation; C reactive protein; Cardioversion; Inflammation; Interleukin

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR RISK; CARDIOVERSION; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART RHYTHM; HOSPITAL DEPARTMENT; HUMAN; INFLAMMATION; MALE; RECURRENT DISEASE; SEX DIFFERENCE;

EID: 34249946296     PISSN: 02105691     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0210-5691(07)74790-3     Document Type: Article

References (29)

1. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis A, Elleboheg E, et al. ACC/AHA/ESC Guidelines for the management of patients with atrial fibrillation: executive summary. Circulation. 2006;114:700-52.
2. Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med. 2000;342:913-20.
3. Val Gelder IC, Crijns HJ, Van Gilst WH, Verter R, Lie KI. Prediction of unenventful cardioversion and maintenance os sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol. 1991;68:41-6.
4. Falk RH. Atrial fibrillation. N Engl J Med 2001;344:1067-78.
5. Bruins P, Velthuis H, Yazdnbakhsh AP, Jansen PG, van Hardevelt FW, Beaumont EM, et al. Activation of the complement system during and after Cardiopulmonary Bypass Surgery. Circulation. 1997;96:3542-8.
6. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, et al. C-reactive protein elevation in patients with atrial arrhytmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 2001;104:2886-91.
7. Dernellis J, Panaretou M. C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal AF. Acta Cardiol. 2001;56:375-80.
8. Watanabe E, Arakawa T, Uchiyama T, Maehara M, Inoue K, Hiramitsu S, et al. CRP as a predictor of success of cardioversion for atrial fibrillation and recurrence after conversion [abstract].Circulation. 2003;108 Suppl IV:IV-708.
9. Conway D, Buggins P, Hughes E, Lip G. Predictive value of indexes of inflammation and hypercoagulability on success of cardioversion of persistent atrial fibrillation. Am J Cardiol. 2004;94:508-10.
10. Zhang H, Heerdt PM, Park B, Fleisher M, Thaler HT. Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein. Chest.2005:128:3421-7.
11. Zarauza J, Rodríguez MJ, Fariñas C, Hernando J, Ceballos B, Gutiérrez B, et al. Relación entre concentraciones de proteína C reactiva y recurrencia precoz de la fibrilación auricular tras cardioversión eléctrica. Res Esp Cardiol. 2006;59:125-9.
12. Gómez E, Borrás S, Sancho S, Faus R, Jarabo M, Martínez ML,et al. Predictive value of inflammatory markers in the recurrence of atrial fibrillation alter electrical cardioversion [abstract]. Intensive Care Med. 2004;30 Suppl 1:S189.
13. Faus R, Borrás S, Simón JM, Porcar E, Campos C, Gómez. E,et al. Influencia de los marcadores de inflamación en la recurrencia de la fibrilación auricular [abstract]. Med Intensiva. 2005; 29 Suppl 1:145.
14. Conway D, Buggins P, Hughes E, Lip G. Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation. Am Heart J. 2004;148:462-6
15. Conway D, Buggins P, Hughes E, Lip G. Relationship of Interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation. J Am Coll Cardiol. 2004;43;2075-82.
16. Anderson JL, Maycock CA, Lappé DL, Crandall BG. Horne BD, Bair TL, et al. Frequency of elevation of C-reactive protein in Atrial Fibrillation. Am J Cardiol. 2004;94:1255-9.
17. Bautista LE, Atwood JE, O'Malley PG, Taylor AJ. Association between C-reactive protein and hypertension in healthy middle-aged men and women. Coron Artery Dis. 2004;15:331-6.
18. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Canon RO III. Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Hearts Association. Circulation. 2003;107;499-511.
19. Pasceri V, Willerson J, Yeh E. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000;102:2165-8.
20. Muñoz T, Martínez S, Vinuesa C, Poveda V, Dudagoitia JL, Iribarren S,et al. Comparación de dos posiciones de electrodos en la cardioversión eléctrica de la fibrilación auricular. Med Intensiva.2006;30(4): 137-42.
21. Muñoz T, Poveda Y, Dudagoitia JL, Martínez S, Vinuesa C, Hernández-López M,et al. Comparación de onda monofásica y bifásica en la cardioversión eléctrica en la fibrilación auricular. Med Intensiva. 2005;29(2):79-82.
22. Sata N, Hamada N, Horinouchi T, Amitani S, Yamashita T, Moriyama Y, et al. C-Reactive Protein and atrial fibrillation: is inflammation a consequence or a cause of atrial fibrillation? Jpn Heart J 2004;45:441-5.
23. Wazni O, Martín D, Marrouche NF, Shaaraoui M, Cheng M, Almahameed S, et al. C-reactive protein concentration and recurrente of atrial fibrillation after electrical cardioversion. Herat. 2005;91;1303-5.
24. Hernández Madrid A. Proteína C reactiva y fibrilación auricular. Un viejo marcador en busca de un nuevo sitio. Rev Esp Cardiol.2006;59:94-8.
25. Dernellis J, Panaretou M. Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation. E Heart J 2004;25:1100-7.
26. Ridker PM, Rifai N, Lowenthal SP. Rapid reduction of C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia. Circulation. 2001;103:1191-3.
27. Dernellis J, Panaretou M. Effect of C-reactive protein reduction on paroxysmal atrial fibrillation. Am Heart J. 2005;150:1064e7-1064e12.
28. Madrid AH, Bueno MG, Rebollo JM, Marin I, Pena G, Bernal E, et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent AF: a prospective and randomized study. Circulation. 2002;106:331-6.
29. Korantazopoulos P, Kolettis TM, Kountouris E, Dimitroula V, Karanikis P, Pappa E, et al. Oral vitamina C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation. Int J Cardiolol. 2005;104:361-2.